All News OssDsign AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 05/07/2024 BST			5-day change	1st Jan Change
9.25 ^SEK	+0.54%		-0.54%	+15.62%

06-25	OssDsign AB Approves Election of Christer Fåhraeus as Ordinary Board Member	CI
05-14	Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024

Annual General Meeting held in OssDsign AB	06-25	AQ
OssDsign AB Approves Election of Christer Fåhraeus as Ordinary Board Member	06-25	CI
Withdrawal of proposed incentive programs and revised proposal on board composition and fees ahead of AGM in OssDsign	06-24	AQ
OssDsign publishes Annual Report 2023	06-04	AQ
5,000 patients treated with OssDsign Catalyst® in the U.S.	05-30	AQ
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN OSSDSIGN AB	05-24	AQ
Change of financial calendar	05-16	AQ
OssDsign Q1 - An accelerating turnaround	05-15	AQ
OssDsign: A new beginning – Q1 review	05-15	AQ
Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024	05-14
OssDsign AB (publ) publishes Q1 2024 interim report	05-14	AQ
OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals	04-29	AQ
OssDsign AB Expands Military Access with New Contract Covering 100 Additional VA Orthopedic Hospitals	04-29	CI
Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.	04-14	CI
OssDsign: Another quarter of triple-digit Catalyst growth expected	04-11	AQ
OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products	04-02	MT
OssDsign awarded long-term agreement with Premier, Inc.	04-02	AQ
OssDsign AB Wins Long-Term Agreement with Premier, Inc	04-02	CI
OssDsign: Update after HC seminar and news in the spinal fusion market	03-07	AQ

No results for this search